llyon
nvoon
abbvon
mrkon
Glider Portfolio

The Healthcare Trade

A new class of blockbuster drugs is reshaping healthcare and creating some of the most valuable companies in medicine. This portfolio anchors on the leaders behind that breakthrough and broadens into large pharmaceutical makers, medical device companies, and biotech.

Investors
94
Trading Days
—
Rebalance
Daily

Performance

ROI 1D
-0.01%
ROI 7D
-3.84%
ROI 30D
+3.25%
TVL

$164.47K

Max APY

—

Allocation

llyon

LLYon

$39,472.44

24%
nvoon

NVOon

$19,736.22

12%
abbvon

ABBVon

$18,091.53

11%
mrkon

MRKon

$14,802.16

9%
pfeon

PFEon

$13,157.48

8%
abton

ABTon

$13,157.48

8%
isrgon

ISRGon

$11,512.79

7%
regnon

REGNon

$11,512.79

7%
vrtxon

VRTXon

$11,512.79

7%
unhon

UNHon

$11,512.79

7%